Central serous chorioretinopathy
Laser treatment for retinal stress
Burnout disease is treatable.
Central serous chorioretinopathy is an eye disease which primarily affects middle-aged people. It involves the collection of fluid under the retina. If this does not revert spontaneously, visual disturbances occur. The illness will then require treatment.
The navigated retina laser Navilas® has been tested and approved for the treatment of different retinal diseases. In addition, the suitability of treatment with Navilas® has also been tested for applications that have not explicitly been tested or approved – including central serous chorioretinopathy (CSCR). Some results have already been published, although the laser has not explicitly been authorized as treatment for this disease. If doctors use laser treatment for CSCR without explicit authorization, this is commonly referred to as “off-label use”. Only the ophthalmologist treating you can decide whether Navilas® treatment is a potential option for your CSCR condition.
Central serous chorioretinopathy (CSCR), also known as central serous retinopathy. From the Greek: pathos = suffering and Latin serum = blood fluid. In everyday life, people also talk about "burnout disease".
Emotional or physical stress, taking cortisone, depression.
A "gray" patch, distorted or blurred vision on one side, changes in the perception of colors and contrast.
Treatment may be provided as a supportive measure in addition to stress reduction. Drug therapy is introduced initially. If it doesn’t work or in the case of a chronic course, the ophthalmologist may revert to laser treatment.